AI-Based CBT Enhancement for Mental Health
(AFFECT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on therapy sessions rather than medication use.
What data supports the effectiveness of the treatment LyssnCBT, LyssnCBT, Lyssn AI Platform, AI-Based Fidelity Feedback Tool?
Research shows that AI-based tools can enhance psychotherapy by providing real-time feedback, improving therapist performance, and increasing patient satisfaction and engagement. Studies have found that AI can help therapists deliver more effective cognitive behavioral therapy (CBT) by offering objective feedback and quality assurance, which can lead to better mental health outcomes.12345
Is AI-based CBT enhancement safe for humans?
The available research does not specifically address safety concerns for AI-based CBT enhancement tools like LyssnCBT, but these tools are generally used to support therapy by providing feedback and improving therapy quality, which suggests they are safe to use as they do not directly interact with patients in a harmful way.12367
How is the treatment LyssnCBT different from other treatments for mental health?
LyssnCBT is unique because it uses artificial intelligence to automatically evaluate the quality of cognitive behavioral therapy (CBT) sessions, providing feedback to therapists to improve their practice. This AI-based approach is scalable, cost-efficient, and helps ensure high-quality therapy by offering real-time recommendations and metrics, which is not typically available in traditional therapy settings.12346
What is the purpose of this trial?
This trial tests a digital tool called LyssnCBT, which helps therapists improve their therapy sessions by providing feedback. The study targets therapists and their clients at community mental health agencies. LyssnCBT uses advanced technology to analyze recorded therapy sessions and offer suggestions for improvement. LyssnCBT is an AI-based software system developed to automatically evaluate therapy sessions, supporting high-quality training and supervision.
Research Team
Torrey A Creed, PhD
Principal Investigator
Director, The Penn Collaborative for CBT and Implementation Science
David Atkins, PhD
Principal Investigator
CEO, Lyssn
Eligibility Criteria
This trial is for therapists, their supervisors, and clients at Philadelphia community mental health centers. Participants must be able to conduct therapy in English, agree to use session recordings for research, and have internet access.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pilot Field Trial
A single-arm pilot field trial to identify and address barriers to implementing LyssnCBT in a community mental health context
Main Trial
A randomized stepped-wedge study comparing LyssnCBT to services as usual across multiple community mental health clinics
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- LyssnCBT
LyssnCBT is already approved in United States for the following indications:
- Cognitive Behavioral Therapy (CBT) for mental health disorders and addiction
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Lyssn.io, Inc.
Industry Sponsor
National Institute of Mental Health (NIMH)
Collaborator